Bio‑Techne (TECH) director gets 1,640 shares, 3,777 options granted
Bio‑Techne (TECH) reported an insider equity update.
Rhea-AI Filing Summary
Bio‑Techne (TECH) reported an insider equity update. A director acquired 1,640 shares of common stock on 10/30/2025 at a reported price of $0, bringing direct beneficial ownership to 10,987 shares after the transaction.
The filing also lists a new derivative award: 3,777 stock options acquired on 10/30/2025 with an exercise price of $60.96 and an expiration date of 10/30/2035. According to the footnote, the option vests on the earlier of the one‑year anniversary of the grant date (10/30/2025) or the date of Bio‑Techne’s 2026 annual meeting of shareholders.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 5,417 shares
Grant/Award
9 txns
Insider
Vessey Rupert
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 3,777 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,640 | $0.00 | $0.00 |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 33,641 contracts for 29,864 underlying shares (Direct);
Common Stock — 10,987 shares (Direct)
Footnotes (1)
- F1. The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.
FAQ
What did BIO-TECHNE (TECH) disclose in this Form 4?
A director acquired 1,640 common shares at $0 on 10/30/2025 and received 3,777 stock options with a $60.96 exercise price expiring 10/30/2035.
What are the terms of the newly reported TECH stock options?
The award covers 3,777 options at an exercise price of $60.96, expiring on 10/30/2035.
When do the new TECH options vest?
Per the footnote, they vest on the earlier of the one‑year anniversary of the grant date (10/30/2025) or the date of the 2026 annual meeting.
What is the insider’s role at BIO-TECHNE (TECH)?
The reporting person is listed as a Director.
AI-generated analysis. How Rhea-AI works. Not financial advice.
